Merrimack Pharmaceuticals
MACK
#8541
Rank
โ‚น21.40 B
Marketcap
โ‚น1,448
Share price
0.00%
Change (1 day)
15.13%
Change (1 year)

EPS for Merrimack Pharmaceuticals (MACK)

EPS in 2024 (TTM): โ‚น1,156

According to Merrimack Pharmaceuticals's latest financial reports the company's current EPS (TTM) is โ‚น1,326. In 2016 the company made an earnings per share (EPS) of -โ‚น1,170 an increase over its 2015 EPS that were of -โ‚น1,263.

EPS history for Merrimack Pharmaceuticals from 2012 to 2024

Annual EPS

Year EPS Change
2024 (TTM)โ‚น1,156
2016-โ‚น1,170-7.35%
2015-โ‚น1,26365%
2014-โ‚น765.44-39.39%
2013-โ‚น1,263-54.01%
2012-โ‚น2,746

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
Sanofi
SNY
โ‚น244.91-81.53%๐Ÿ‡ซ๐Ÿ‡ท France
Geron
GERN
-โ‚น12.44-100.94%๐Ÿ‡บ๐Ÿ‡ธ USA
Clovis Oncology
CLVS
-โ‚น180.84-113.64%๐Ÿ‡บ๐Ÿ‡ธ USA
AVEO Oncology
AVEO
-โ‚น80.37-106.06%๐Ÿ‡บ๐Ÿ‡ธ USA
Eterna Therapeutics
ERNA
-โ‚น7,340-653.46%๐Ÿ‡บ๐Ÿ‡ธ USA